NCT03189043 is a Phase 2 clinical trial of Antimicrobial Surface in Healthcare Associated Infection, sponsored by Aionx, Inc..

Who is sponsoring NCT03189043?

NCT03189043 is sponsored by Aionx, Inc..

What drugs are being tested in NCT03189043?

Interventions in NCT03189043: Antimicrobial Surface.

What condition does NCT03189043 study?

NCT03189043 studies Healthcare Associated Infection.

Is NCT03189043 still recruiting?

NCT03189043 is currently status unknown. Last updated 16 June 2017.

Last reviewed 2017-06-16 · How we verify

NCT03189043

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections

Status unknown Phase 2 Last updated 16 June 2017

What this trial tests

Phase 2 trial testing Antimicrobial Surface in Healthcare Associated Infection in 10,000 participants. Status unknown.

Timeline

1 July 2017

Primary endpoint
1 October 2017

1 October 2017

Quick facts

Lead sponsor	Aionx, Inc.
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	none
Primary purpose	prevention
Enrollment	10,000
Start date	1 July 2017
Primary completion	1 October 2017
Estimated completion	1 October 2017

Drugs / interventions tested

Antimicrobial Surface

Conditions studied

Healthcare Associated Infection — all drugs for Healthcare Associated Infection →

Sponsor

Aionx, Inc.

Who can join

18 and older, any sex, with Healthcare Associated Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a controlled open label efficacy study of Aionx antimicrobial surface for the prevention of healthcare-associated infections.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthcare Associated Infection

Currently open trials in the same condition.

NCT06420934 — Surgical Handwashing: Drying With One or Two Surgical Towels · NA · recruiting
NCT06739863 — Evaluation of Healthcare Waste Management Practices and Problems Among Primary and Secondary Hospitals · active not recruiting
NCT05979545 — EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics · Phase 4 · recruiting
NCT06155747 — Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt) · recruiting
NCT05612672 — Evaluation of GeoHAI Implementation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03189043 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aionx, Inc.
Last refreshed: 16 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03189043.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing